Simile
-64%
est. 2Y upside i
Rank
#1765
Sector
Artificial Intelligence, Enterprise Software
Est. Liquidity
~6Y
Data Quality
Data: MediumSimile presents a moderate upside opportunity for a job seeker, driven by its innovative human behavior prediction AI and a strong founding team in a rapidly expanding market.
Last updated: March 10, 2026
Simile's proprietary human behavior foundation model achieves widespread enterprise adoption, becoming the de-facto standard for predictive market research and strategic planning. This drives revenue to over $500M by 2028, justifying a $2.25B+ valuation at 4.5x the current assumed valuation, despite incumbent competition.
Simile successfully carves out a niche in the enterprise AI simulation market, growing steadily but facing intense competition from large AI labs. Revenue reaches $150M by 2028, leading to an exit valuation of approximately $600M, a modest increase from the current assumed valuation.
Dominant incumbents like Google and Microsoft launch directly competing, highly integrated human simulation platforms, commoditizing Simile's offering. This leads to stalled growth, a down round to $75M, and significant loss of common stock value for employees given the $100M liquidation preference.
Preference Stack Risk
highInvestors hold $100M in liquidation preferences ahead of common stock, representing 20% of the assumed $500M post-money valuation.
Dilution Risk
moderateAs a Series A company, Simile will likely require additional funding rounds, which will lead to further dilution of existing equity holders.
Secondary Liquidity
limitedSecondary market activity exists, but investor demand is currently outstripping the supply of available shares.
Questions to Ask at the Interview
Strategic questions based on Simile's data — designed to show you've done your homework.
- 1
“Given the high incumbent threat from large AI labs like OpenAI, Google, and Microsoft, how does Simile plan to differentiate its platform and maintain its competitive moat in the long term?”
- 2
“With a strong focus on enterprise clients like CVS Health, what is Simile's strategy for scaling customer acquisition and expanding into new market segments to capture the identified $4.0B SAM?”
- 3
“Considering the Series A funding and the typical timeline for liquidity events, what is the company's anticipated path and timeline towards an IPO or acquisition, and how might future funding rounds impact employee equity?”
Community
Valuation Sentiment
Our model estimates -64% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.